Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	49.95	81.90	54.62
Graham Fair Price	27.25	2.83	2.23
PEG	-4.64	0.39	0.40
Price/Book	-17.13	0.52	0.63
Price/Cash Flow	-43.60	-129.75	-90.36
Prices/Earnings	-38.92	18.65	30.54
Price/Sales	31.45	16.53	12.57
Price/FCF	-43.60	-129.75	-90.36
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	20.47	0.37	0.30
Operating Margin	885.55	0.34	0.03
ROA	31.39	< 0.005	< 0.005
ROE	< 0.005	< 0.005	35.69
ROIC	< 0.005	< 0.005	290.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.24	-80.93
Dividends QOQ	-0.78	-0.57	26.60
EBIT QOQ	-0.75	5.26	605.00
EPS QOQ	0.76	0.48	-35.95
FCF QOQ	0.47	0.42	-10.85
Revenue QOQ	0.71	-0.37	-48.86
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	270.41	500.09	84.94
Days Sales Outstanding (DSO)	53.50	79.24	48.12
Inventory Turnover	0.33	0.18	-45.93
Debt/Capitalization	0.15	0.15	3.25
Quick Ratio	0.45	0.49	8.61
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.53	7.13	9.24
Cash	0.97	1.38	41.73
Capex	-0.05	-0.05	-3.51
Free Cash Flow	-0.05	-0.03	36.96
Revenue	0.33	0.23	-31.13
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.87	0.87	-0.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.42	0.61	-82.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating